| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |